2. 您的位置
3. 首页
4. 会议论文
5. Efficacy and safety of Infliximab in juvenile idiopathic arthritis and juvenile ankylosing spondylit

Efficacy and safety of Infliximab in juvenile idiopathic arthritis and juvenile ankylosing spondylit

来源 :中华医学生物免疫学会第二届学术年会 | 被引量 : 0次 | 上传用户：lhawk

【摘 要】

：

objective :The randomized method was designed to observe the efficacy and safety ofinfliximab for juvenile idiopathic arthritis (JIA) and juvenile ankylosing spondylitis (JAS).This study will provide

【作 者】

：

曾萍 曾华松 李丰 唐盈 王敏 

【机 构】

：

广州市妇女儿童医疗中心过敏免疫风湿病科

【出 处】

：

中华医学生物免疫学会第二届学术年会

【发表日期】

：

2014年5期

【关键词】

：

juvenile idiopathic arthritis juvenile ankylosing spondylitis infliximab 

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　objective :The randomized method was designed to observe the efficacy and safety ofinfliximab for juvenile idiopathic arthritis (JIA) and juvenile ankylosing spondylitis (JAS).This study will provide evidence-based medical evidence in the application of infliximab for pediatric rheumatology.

其他文献

A clinical study on anti-HBV-DC-MTL in the HBeAg negative chronic hepatitis B virus infection

Aims:To observe the clinical efficacy of anti-HBV-DC-MTL,the dendritic cells(DC) and mixed T lymphocyte(MTL)originating from PBMC sensitized by HBsAg,in HBeAg negative chronic hepatitis B virus(HBV) i

会议

A clinical trial on anti-HBV-DC combined with lamivudine and thymosin -a1 in the HBeAg positive pati

Background and aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells(DC) originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with la

会议

A clinical trial on anti-HBV-DC vaccine combined with thymosin-α 1 in the HBeAg negative patients of

Aims:To observe the clinical efficacy of anti-HBV-DC vaccine,the dendritic cells originating from peripheral blood mononuclear cells(PBMC) sensitized by HBsAg,in combination with thymosin-α 1,in the H

会议

The clinical features of juvenile idiopathic arthritis and efficacy analysis of tumor necrosis facto

Objective Observe the cIinical effects and features of tumor necrosis factor antagonists (Etanercept) in treatment of systemic onset juvenile idiopathic arthritis (So-JIA),to provide the basis evidenc

会议

The changes and significances of serum IL-6 and IL-15 level in juvenile rheumatoid arthritis

Objective:Analyze the changes and significance of serum IL-6,IL-15 level in juvenile rheumatoid arthritis patients.Methods:Collect serum samples of 31 cases of juvenile rheumatoid arthritis children a

会议

juvenile rheumatoid arthritisIL-6IL-15

Discussion the correlation of anaphylactoid purpura children in gastrointestinal lesions and helicob

Objective:To explore the correlation of changes in gastrointestinal endoscopy change and helicobacter pylori infection of children with allergic purpura.Methods:Electronic endoscopy for 87 cases of al

会议

Allergic purpuraHastroscopyHelicobacter pylori

The clinical observation of immunoadsorption in treatment of children with refractory autoimmune dis

Objective:Explore the clinical efficacy and safety of the immunoadsorption assisted treatment of children with refractory autoimmune diseases.Methods:Use HA280 type resin perfusion machine for four ti

会议

Immunity adsorptionAllergic purpuraJuvenile idiopathic arthritisDermatomyosit

Early diagonostic and predictive value of antikeration antibody,anti-cyclic citryllinated peptide an

Objective To investigate the value of antikeration antibody (AKA),anti-cyclic citrullinated peptide antibody (antiCCP) and rheumatoid factor (RF-IgG,RF-IgM) in early diagnosis and prediction of juveni

会议

antikeratin antibodyanti-cyclic citrullinated peptide antibodyrheumatoid facto

The significance of early diagnosis and prognostic evaluation of four kinds of anti-CCP antibodies i

Objective:Investigate the relationship between immunological parameters AKA,anti-CCP,the RF-IGG,RF-IGM and the early diagnosis and prognosis in sub-JIA patients.Methods:Collection of 76 JIA patients i

会议

AKAanti-CCPRF-IGGRF-IGMjuvenile idiopathic arthritisearly diagnosisprognos

A randomized controlled clinical trial to evaluate the efficacy of Recombinant Human Tumor Necrosis

Objective:Research the Recombinant Human Tumor Necrosis Factor-α Receptor type Ⅱ fusion protein antibody (Etanercept)for Treatment of juvenile idiopathic arthritis (JIA).A randomized double-blind cont

会议

recombinant human tumor necrosis factor-α receptor type-Ⅱ fusion protein antibod